Decision Makers
Board of Directors
Arthur P. Bollon, Ph.D. - Dr. Bollon brings 25 years experience in biotechnology as a scientist, executive and entrepreneur. He has been the Chairman, President and CEO of HemoBioTech since 2003. - Founder, former Chairman & CEO of Wadley Biosciences Inc., a joint venture between Wadley Cancer Center and Phillips Petroleum. - Founder, former Chairman & CEO of Cytoclonal Pharmaceutics a " led an IPO in 1995 and closed licensing agreement with Bristol Meyers Squibb. - Dr. Bollon holds a Ph.D. in molecular genetics from Rutgers University and was a Post Doctoral Fellow at Yale University.
| Organization |
Position |
Status |
| Hemobiotech, Inc. |
Chairman of the Board of Directors, President and Chief Executive Officer |
Current |
| Biogress LLC. |
Co-Founder |
Former |
| Hemobiotech, Inc. |
Scientist |
Former |
| Yale University |
Fellow |
Former |
| University of Texas Health Science Center |
Assistant Professor |
Former |
| Rutgers University |
Ph.D. In Molecular Genetics |
Former |
- Mark Rosenblum joined as the Chief Financial Officer of HemoBioTech on April 1, 2005. - Former Vice President, Chief Accounting Officer & Controller at Wellman, Inc., a $1.2 billion public chemical manufacturer. - Mark Rosenblum holds a master's in accounting and B.S. in accounting from the University of South Carolina. Mr. Rosenblum is also a certified public accountant. Jan Simoni, Ph.D., D.V.M. - Dr. Simoni is the co-inventor of HemoTech and a world-renowned blood substitute scientist. - He is the Acting Vice President of R & D and Advisor at HemoBioTech and Associate Research Professor of Surgery and Internal Medicine at Texas Tech University Health Science Center. - Co-author of over 100 publications, book chapters, and abstracts on human blood substitutes. - Dr. Simoni holds a DVM and a Ph.D. from Wroclaw Agricultural University in Poland.
| Organization |
Position |
Status |
| Hemobiotech, Inc. |
Acting Vice President, Research and Development An |
Current |
| Texas Tech |
Blood Substitute Group Leader |
Current |
| Organization |
Position |
Status |
| Hemobiotech, Inc. |
Co-Founder and Vice Chairman |
Current |
| Pave Systems, Inc |
Founder |
Former |
| Ascend Mobility |
Founder |
Former |
| Biogress LLC. |
Co-Founder |
Former |
| Ascend |
Director |
Former |
| Organization |
Position |
Status |
| Potomac Institute for Policy Studies |
Senior Fellow |
Current |
| Washington Suburban Sanitary Commission |
Commissioner |
Current |
| Hemobiotech, Inc. |
Scientific Advisor |
Current |
| Montgomery Gen Hospital, Inc. |
Board of Directors |
Current |
| The Johns Hopkins University |
PhD In Epidemiology |
Former |
| University of Michigan |
Master of Public Health In Epidemiology |
Former |
Walter Haeussler, Advisor. Mr. Haeussler, retired from the private practice of law, served as a member of our Board of Directors from March 2004 to January 2008 and currently serves as a member of our Advisory Board. Between August 1998 and August 2002, Mr. Haeussler served as the Director of Technology Transfer at Texas Tech University. Between August 2002 and March 2004, he served as General Counsel to Advisys Inc., an animal biotech company. Between July 1993 and August 1998, Mr. Haeussler served as the President of the Cornell Research Foundation at Cornell University. Between 1972 and 1983, Mr. Haeussler was the Managing Partner of Jones Tallar & Cooper, an intellectual property law firm. Mr. Haeussler serves as a member of the Board of Directors of Thoriun Power, Inc., an alternate energy source company. Mr. Haeussler received his J.D. degree from Duquesne University.
| Organization |
Position |
Status |
| Yale School of Management |
Advisory Director |
Current |
| Landec Corporation |
Vice Chairman and Director of Lehman Brothers |
Current |
| Harvard School of Public Health |
Advisory Director |
Current |
| PureTech Ventures |
Senior Advisor |
Current |
| Salk Institute |
Director |
Current |
| Orbimed Advisors, LLC |
Chairman of The Board |
Current |
| Epix, Inc. |
Chairman of The Board |
Current |
| Predix Pharmaceuticals Holdings, Inc. |
Chairman of The Board |
Current |
| Business Engine, Inc. |
Director |
Current |
| Hemobiotech, Inc. |
Vice Chairman of Lehman Brothers |
Current |
| Egeen Intl. Corp. |
Vice Chairman |
Current |
| Kinemed, Inc |
Vice Chairman |
Current |
| EPIX Pharmaceuticals, Inc. |
Board of Directors |
Current |
| Institute for Systems Biology |
Director |
Current |
| Celtic Pharma |
Vice Chairman |
Current |
| Ophthalmopharma AG. |
Board of Directors |
Current |
| Pharmaceutical Product Development, Inc. |
Director |
Current |
| Diagnostic Products Corporation |
Director |
Current |
| 1-800-Doctors, Inc. |
Director |
Current |
| EPIX Pharmaceuticals, Inc. |
Board of Directors |
Current |
| New York Society of Security Analysts |
Board of Directors |
Current |
| PDL BioPharma, Inc. |
Board of Directors |
Current |
| Peter J. Solomon Company |
Vice Chairman |
Current |
| Harvard School of Public Health |
Advisory Board Member |
Current |
| eSoft, Incorporated |
Director |
Current |
| New York Society of Security Analysts |
Member |
Current |
| Smith Barney |
Vice President |
Former |
| Lehman Brothers Holdings Inc. |
Senior Managing Director |
Former |
| Lehman Brothers Holdings Inc. |
partner |
Former |
| Swedish American Life Science |
Board of Directors |
Former |
| Lehman Brothers Holdings Inc. |
Director |
Former |
| Lehman Brothers Holdings Inc. |
Vice Chairman |
Former |
| Barclays Capital |
Vice Chairman |
Former |
| Landec Corporation |
Board of Directors |
Former |
| Stanford University |
MBA |
Former |
| Stanford Graduate School of Business |
MBA |
Former |
| Yale University |
B.A. |
Former |
Executive News